UNC Lineberger researchers find how triple negative breast cancer cells are able to bypass treatment with trametinib, an FDA-approved drug. The researchers also used lab models of breast cancer to test a potential treatment approach that could prevent resistance.
UNC Lineberger researchers Ethan Basch, MD, MSc, and Stephanie Wheeler, PhD, MPH, called for tailored, local-level cancer prevention, screening and treatment efforts to address regional disparities in cancer mortality rates in an editorial published in JAMA on Tuesday.
Past winners include six scientists who went on to win the Nobel Prize.
UNC, NCSU biomedical engineering research team’s findings show that engineered platelets can deliver antibodies to kill cancer cells before they can grow or spread elsewhere in the body.
According to Anthony Charles, MD, MPH, of the UNC School of Medicine, the WHO should amend its centralization policy to help doctors save lives in Sub-Saharan Africa.
UNC's Dr. David Weber and Dr. William Rutala are co-authors of the study, which found that adding UV light to standard cleaning cut transmission of 4 resistant bacteria by 30 percent.
To ensure the safety of our patients, children ages 11 and younger are prohibited from visiting inpatient areas and waiting rooms at UNC Hospitals (at the Chapel Hill and Hillsborough locations) beginning Monday, Jan. 23, 2017.
This innovative model expands services available to patients.
Unmasking a previously misunderstood gene, University of North Carolina scientists discover an unlikely potential drug target for gastrointestinal cancers.
By focusing on small molecules called microRNAs in stem cells of the intestine, UNC School of Medicine researchers have proposed a new mechanism by which gut microbes might help keep us healthy or make us sick.
UNC clinical geneticists are part of a national consortium of researchers studying the ins and outs of genome sequencing for newborn health screenings and beyond.
New research led by scientists at the UNC School of Medicine and NC State University demonstrates the effectiveness of using prebiotics to change the composition of the gut microbiome of those suffering from lactose intolerance.
In a perspective published in the New England Journal of Medicine, Ethan Basch, MD, MSc, professor of medicine and director of UNC Lineberger’s Cancer Outcomes Research Program, addressed the need for – and the barriers preventing – electronic reporting of patients’ symptoms between visits.
UNC research shows test scores don’t forecast productivity or success in graduate programs within the experimental sciences.
UNC School of Medicine researchers, led by Cindy Wu, MD, used a crowdsourcing model to identify what potential patients value most when seeking an aesthetic surgeon.
UNC scientists conduct seminal experiments to unveil how early-in-life visual experiences – simply trying to see – sculpt a particular subnetwork of brain circuitry we need in order to see properly.
Optogenetics Breakthrough: UNC scientists expand the use of light to control protein activity in cells
The new research technique, developed by researchers at the UNC School of Medicine and UNC Lineberger Comprehensive Cancer Center, has the potential to illuminate the roles of previously inaccessible proteins important for health and disease.
A start-up company co-founded by UNC Lineberger researcher Andrew Wang has raised $2.9 million to commercialize a test designed to capture cancer cells circulating in the blood.
Less than a year after she earned her degree from UNC, Misty Cox is already putting her skills to work — and helping make North Carolinians healthier in the process. Cox, a 2016 UNC-Chapel Hill graduate, is one of 13 fellows participating in MedServe, a program focused on helping solve the problem of health care shortages across North Carolina. The program was co-founded by Patrick O'Shea, a UNC School of Medicine Student.